Nature’s antivenom: Combinations of conserved rattlesnake serum metalloproteinase inhibitors block the lethal action of viper venoms
Proceedings of the National Academy of Sciences, Volume 123, Issue 32, August 2026. SignificanceSnakebite remains an undertreated tropical disease that affects over one million people annually, and new therapeutic approaches are needed. Here, we develop an approach to viper antivenoms inspired by the observations that these snakes are ...
We haven't written up this one. PNAS has the full story — the link below goes straight to it.
